Evidence map›Paper›PMID 39139438›Full record

ReviewReviews in cardiovascular medicine2024

Role of Trimethylamine N-Oxide in Heart Failure.

Lele Jing, Honghong Zhang, Qiannan Xiang, Huilin Hu, Changlin Zhai, Suining Xu, Hongen Tian

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lele JingAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
Honghong ZhangAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
Qiannan XiangAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
Huilin HuAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
Changlin ZhaiAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
Suining XuDepartment of Cardiology, The First Affiliated Hospital, Xi'an Jiaotong University, 710061 Xi'an, Shaanxi, China.
Hongen TianAffiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the heart. HF is often the final stage of all cardiovascular diseases and a significant risk factor for sudden cardiac arrest, death, and liver or kidney failure. Current pharmacological treatments can only slow the progression and recurrence of HF. With advancing research into the gut microbiome and its metabolites, one such trimethylamine N-oxide (TMAO)-has been implicated in the advancement of HF and is correlated with poor prognosis in patients with HF. However, the precise role of TMAO in HF has not yet been clarified. This review highlights and concludes the available evidence and potential mechanisms associated with HF, with the hope of contributing new insights into the diagnosis and prevention of HF.

Indexed as

fecal microbiota transplantation (FMT)gut microbiotaheart failureinflammatory responsemitochondrial dysfunctionTMAO

Identifiers

PMID39139438
PMCPMC11317343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.